Ceftazidime/avibactam for treatment of pleural empyema due to carbapenem-resistant serratia marcescens

Research output: Contribution to journalLetter

Original languageEnglish (US)
Number of pages1
JournalInfectious Diseases in Clinical Practice
Volume24
Issue number2
DOIs
StatePublished - Jan 1 2016

Fingerprint

Pleural Empyema
Serratia marcescens
Carbapenems
ceftazidime drug combination avibactam

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Infectious Diseases

Cite this

@article{800ddca8cba54a2aa8e7c3bc2f500bfd,
title = "Ceftazidime/avibactam for treatment of pleural empyema due to carbapenem-resistant serratia marcescens",
author = "Kerry Cleveland and Michael Gelfand",
year = "2016",
month = "1",
day = "1",
doi = "10.1097/IPC.0000000000000357",
language = "English (US)",
volume = "24",
journal = "Infectious Diseases in Clinical Practice",
issn = "1056-9103",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Ceftazidime/avibactam for treatment of pleural empyema due to carbapenem-resistant serratia marcescens

AU - Cleveland, Kerry

AU - Gelfand, Michael

PY - 2016/1/1

Y1 - 2016/1/1

UR - http://www.scopus.com/inward/record.url?scp=84959921579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959921579&partnerID=8YFLogxK

U2 - 10.1097/IPC.0000000000000357

DO - 10.1097/IPC.0000000000000357

M3 - Letter

VL - 24

JO - Infectious Diseases in Clinical Practice

JF - Infectious Diseases in Clinical Practice

SN - 1056-9103

IS - 2

ER -